PhotoMedex (PHMD +3.8%) gets a lift today after upping its Q4 revenue forecast, citing...
PhotoMedex (PHMD +3.8%) gets a lift today after upping its Q4 revenue forecast, citing higher-than-expected sales in its consumer segment due to a strong response to its holiday advertising. The company - whose products address skin problems such as psoriasis and acne - now projects revenue for the current quarter of between $52M to $54M, versus prior estimates of $46M to $48M.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs